Novus Biologicals products are now on bio-techne.com

Immunology

Advancing CAR T Therapies with CRISPR/Cas9

You complete me: Natural killer cells need TGF-beta inhibition to effectively combat cancers

Meningeal lymphatics: recent discovery defying the concept of central nervous system 'immune privilege'

Antigen-loss relapse after successful CAR-T therapy; What do we do now?

Acute lymphoblastic leukemia disease bioinformatics

By Jacqueline Carrico, BS, MD

MAPK Signaling Links Autophagy and Inflammation

Adenosine Inhibits T cell Tumor Infiltration: KCa3.1, a New Anticancer Target

Novel Approaches to Improve Efficacy and Safety of CAR-T Therapy

CAR-T Therapy

By Jacqueline Carrico, BS, MD Candidate

Immunity’s flipside: Microglia promote Alzheimer’s pathology during inflammation

The role of STING/TMEM173 in gamma and encephalitis Herpes Simplex Virus (HSV)

Stimulator of interferon genes (STING), also known as TMEM173, promotes the production of the interferon’s IFN-alpha and IFN-beta.  STING possesses three functional domains: a cytoplasmic C-terminal tail, a central globular domain, and four N-terminal transmembrane motifs that attach it to the ER.  The role of STING in the immune response is specific to its ability to sense nucleic acids, particularly dsDNA.

Article Review: Effects of the administration of high-dose interleukin-2 on immunoregulatory cell subsets in patients with advanced melanoma and renal cell cancer

The immune system is composed of a portion of T cells that express an invariant T cell receptor (TCR) alpha chain known as V alpha 24 J alpha 18. These highly conserved populations are referred to as iNKT populations and have the ability to rapidly produce cytokines following activation, making them hot targets for therapeutic research initiatives.

Pages